Galapagos NV
USPTO PatentsView assignee record - 84 granted patents across 14 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Galapagos ranks #4,240 of 49,997 tracked US assignees by granted-patent volume, with 84 patents across 14 technology areas.
- #4,240
- of 49,997 US assignees by volume
- Top 34%
- by Innovation Score (41.2/100)
- 17.9
- avg claims per patent
- -42%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R4240 · Foreign Corporation #4,240 · 84 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 84 grants
- TOP-DECILE #4,240/49,997
- PHOTO-FINISH Festo & KG
- CPC-FOCUS A61P · 14 areas
- INNOV-PAR 41.2/100
- CLAIMS-RICH 17.9 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -42% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Festo AG & Co. KG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Galapagos’s 41.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Galapagos
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Capital One Financial · near
Capital One Financial · near
41 score
- Control Techniques · near
Control Techniques · near
41 score
- Galapagos · this assignee
Galapagos · this assignee
41 score
- Mersana Therapeutics · near
Mersana Therapeutics · near
41 score
- Surpass Industry · near
Surpass Industry · near
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Galapagos's Innovation Score is 41.2/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Galapagos?
Each dot is one of Galapagos’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Galapagos’s own 17.9 claims/patent is ABOVE the 11.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Galapagos's grants concentrate
Galapagos NV is a focused PatentsView assignee: 14 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (16 grants) versus a trough of 3 in 2022. By volume, Galapagos sits between Flipboard, Inc. and Inovio Pharmaceuticals, Inc..
Galapagos's three-year grant acceleration
From 2019–2021 to 2022–2024, Galapagos NV moved from 32 to 9 grants (0.28x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Galapagos's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Flipboard
Flipboard, Inc.
84 patents
- Festo & KG
Festo AG & Co. KG
84 patents
- GN Netcom A/S
GN Netcom A/S
84 patents
- Guangdong Gopod G…
Guangdong Gopod Group Holding Co., Ltd.
84 patents
- Ignite USA
Ignite USA, LLC
84 patents
- Imra America
Imra America, Inc.
84 patents
- Inmar Clearing
Inmar Clearing, Inc.
84 patents
- Inovio Pharmaceut…
Inovio Pharmaceuticals, Inc.
84 patents
- Galapagos ◀
Galapagos NV
84 patents
What this shows Galapagos holds 84 patents at rank #4,242, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Galapagos
By rank, the assignees closest to #4,242 in granted patent volume.
- Flipboard, Inc. #4,238 · 84 patents
- Festo AG & Co. KG #4,239 · 84 patents
- GN Netcom A/S #4,240 · 84 patents
- Guangdong Gopod Group Holding Co., Ltd. #4,241 · 84 patents
- Ignite USA, LLC #4,243 · 84 patents
- Imra America, Inc. #4,244 · 84 patents
- Inmar Clearing, Inc. #4,245 · 84 patents
- Inovio Pharmaceuticals, Inc. #4,246 · 84 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Galapagos's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Galapagos, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Galapagos ranks #187 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (41 here).
Similar claim depth
Nearest assignees by average claims per patent (17.9 here).
Galapagos's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 7.1% |
| 2016 | 11 | 13.1% |
| 2017 | 8 | 9.5% |
| 2018 | 16 | 19.0% |
| 2019 | 11 | 13.1% |
| 2020 | 14 | 16.7% |
| 2021 | 7 | 8.3% |
| 2022 | 3 | 3.6% |
| 2023 | 3 | 3.6% |
| 2024 | 3 | 3.6% |
| 2025partial year | 2 | 2.4% |
Which technologies does Galapagos NV patent most?
Top 14 of 14 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Galapagos NV's patent record in context - here's where to go next.
- Galapagos NV's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #4,240 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Galapagos NV against Flipboard, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 41.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.